周彩存—晚期非小细胞肺癌内科治疗的个体化.pptVIP

晚期非小细胞肺癌内科治疗的个体化 同济大学附属上海市肺科医院 周彩存 晚期非小细胞肺癌的治疗现状 Platinum-based doublets improve overall survival Prolonged chemotherapy more than 3-4 cycles could not further improve efficacy Doublets plus avastin or cetuximab improve overall survival compared with doublets Chemotherapy could improve disease-related symptoms Chemotherapy has toxicities Advanced lung cancer could not be cured and our aim is to make it chronic disease 个体化治疗 Definition - 4R: Right agent, right dose, right patients and right timing - Biomarkers：predictive, prognostic - Purpose: improvemen